fbpx
previous arrow
next arrow
Slider

The development of prenatal molecular testing has progressed from the early large segment chromosomal abnormality observation method, to DNA microarray technology, then into whole genome sequencing (WGS) and whole exome sequencing (WES), with every stage having its own advantages and disadvantages. However, compared with other molecular testing methods, WGS and WES are able to screen for fetal chromosomal abnormalities more comprehensively in specific cases. 

Yourgene Health invited Dr. Shu-Han You from the Department of Gynecology and Obstetrics in Chang Gung Memorial Hospital, Linkou, to share their medical team’s prenatal clinical testing experiences with WES technology.

Click here to view the case studies in English
Click here to view the case studies in Mandarin

Dr. Shu-Han You


In the unlikely event that you do not have the Adobe Reader installed you can get it by clicking the button below:

get adobe reader